Key result
Cambridge Risk Score identifies undiagnosed diabetes with ~84% discrimination and metabolic syndrome with ~78% discrimination.
Cross-Sectional (n=1,355)
No
Answers are grounded in this paper and cite their sources.
AIMS: To assess the performance of a risk score comprising data routinely available in general practice records (age, gender, body mass index, family history of diabetes, smoking habits and prescribed anti-hypertensive drugs or steroids) in detecting diabetes, impaired glucose tolerance and metabolic syndrome. METHODS: In a population-based, cross-sectional study in a semi-rural general practice in Jutland, Denmark, Cambridge Risk Scores were calculated for 1355 patients without known diabetes (69% response rate) who completed questionnaires and underwent anthropometric measurement and an oral glucose tolerance test. RESULTS: Prevalences of diabetes, impaired glucose tolerance and metabolic syndrome were 2.29% (95% CI: 1.56-3.23), 6.64% (95% CI: 5.38-8.10) and 13.4% (95% CI: 11.5-15.2), respectively. Area under the ROC curve for the risk score and diabetes was 83.8% (75.9-91.7) and for metabolic syndrome [European Group for the Study of Insulin Resistance (EGIR)] was 78.1% (74.6-81.6). Twenty per cent of the population had a risk score above 0.246; at this threshold the sensitivity to detect diabetes was 71.0% (53.4-83.9), the specificity 81.2% (79.0-83.2), positive predictive value 8.1% (6.6-10.0) and likelihood ratio 3.77 (2.94-4.85). For metabolic syndrome (EGIR) corresponding values for sensitivity were 50.3% (43.1-57.5), specificity 84.7% (82.5-85.6), positive predictive value 33.6% (28.2-39.4), and likelihood ratio 3.28 (2.69-4.00). CONCLUSIONS: Undiagnosed hyperglycaemia and metabolic syndrome are common. The Cambridge Risk Score is a practical first step in a screening procedure to identify individuals with these disorders who might benefit from diagnostic testing or to direct preventive interventions.
No takes yet. Share an insight, caveat, or question.
Heldgaard et al. (2006) conducted a cross-sectional in Undiagnosed diabetes, impaired glucose tolerance, and metabolic syndrome (n=1,355). Cambridge Risk Score vs. Oral glucose tolerance test and European Group for the Study of Insulin Resistance (EGIR) criteria was evaluated on Detection of diabetes and metabolic syndrome (EGIR) (AUC 83.8% for diabetes; AUC 78.1% for metabolic syndrome, 95% CI 75.9-91.7). The Cambridge Risk Score identified undiagnosed diabetes with an AUC of 83.8% and metabolic syndrome with an AUC of 78.1%.
Synapse has enriched 10 related papers. Consider them for comparative context: